INSPIRE: a Multi-Cancer Early Detection Study

Summary

This research constitutes a multi-centric, case-control designed investigation aimed at developing and implementing a blinded validation of a machine learning-powered, multi-cancer early detection model. This is to be achieved through the prospective collection of blood specimens from newly diagnosed cancer patients and individuals devoid of a confirmed cancer diagnosis

Conditions

• Lung Cancer
• Gastric Cancer
• Liver Cancer
• Colorectal Cancer
• Pancreatic Cancer
• Esophageal Cancer
• Breast Cancer
• Cervical Cancer
• Ovarian Cancer
• Endometrial Cancer
• Bladder Cancer
• Prostate Cancer
• Cholangiocarcinoma

Sponsors & Collaborators

• Fudan University

  collaborator OTHER

• Hubei Cancer Hospital, Huazhong University of Science and Technology

  collaborator UNKNOWN

• China-Japan Friendship Hospital

  collaborator OTHER

• Shaanxi Provincial Cancer Hospital

  collaborator OTHER

• Xuhui Central Hospital, Fudan University

  collaborator UNKNOWN

• Shanghai Electric Power Hospital

  collaborator UNKNOWN

• East Hospital, Tongji University

  collaborator UNKNOWN

• The First Affiliated Hospital of Xi' an Jiaotong University

  collaborator UNKNOWN

• GaoZhou People's Hosipital

  collaborator UNKNOWN

• Anhui Provincial Hospital

  collaborator OTHER_GOV

• Beijing Friendship Hospital

  collaborator OTHER

• Singlera Genomics Inc.

  lead INDUSTRY

Eligibility

Min Age

40 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-07-20

Primary Completion

2025-02-28

Completion

2025-02-28

Countries

• China

Study Locations